Your browser doesn't support javascript.
loading
The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs.
Sharko, Amanda C; Lim, Chang-Uk; McDermott, Martina S J; Hennes, Chuck; Philavong, Kingsavanh P; Aiken, Tiffanie; Tatarskiy, Victor V; Roninson, Igor B; Broude, Eugenia V.
Afiliación
  • Sharko AC; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
  • Lim CU; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
  • McDermott MSJ; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
  • Hennes C; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
  • Philavong KP; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
  • Aiken T; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
  • Tatarskiy VV; Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia.
  • Roninson IB; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
  • Broude EV; Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC 29208, USA.
Cells ; 10(1)2021 01 12.
Article en En | MEDLINE | ID: mdl-33445730

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinasas Ciclina-Dependientes / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Quinasa 8 Dependiente de Ciclina / Terapia Molecular Dirigida / Receptores ErbB Límite: Humans Idioma: En Revista: Cells Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinasas Ciclina-Dependientes / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Quinasa 8 Dependiente de Ciclina / Terapia Molecular Dirigida / Receptores ErbB Límite: Humans Idioma: En Revista: Cells Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos